Shanrong Biotechnology Corp. (SRBT) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Shell Companies Branche. Der Hauptsitz des Unternehmens ist in Beverly Hills, CA, United States. Der aktuelle CEO ist Colonel Timothy D. Ringgold.
SRBT hat IPO-Datum 2018-02-09, gelistet an der Other OTC, eine Marktkapitalisierung von $298.00.
Shanrong Biotechnology Corp. operates as a project management and executive consulting company. The company refurbishes and upgrades armored vehicles with digital communications, as well as provides spare parts and equipment for military and police forces; and offers onsite maintenance, maintenance training, operator training, and tactical training services. It also conducts program management, business development, and strategic studies and analyses in the defense, homeland security, information technology, and telecommunications markets. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017. Shanrong Biotechnology Corp. is based in Beverly Hills, California.
